Fingerprint
Dive into the research topics of 'Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition
Tim Kong, Angelo B.A. Laranjeira, Taylor B. Collins, Elisa S. De Togni, Abigail J. Wong, Mary C. Fulbright, Marianna Ruzinova, Hamza Celik, Grant A. Challen, Daniel A.C. Fisher, Stephen Oh
- Division of Anatomic and Molecular Pathology (AMP)
- Institute of Clinical and Translational Sciences (ICTS)
- Section of Stem Cell Biology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Siteman Cancer Center
- Division of Hematology
- Department of Medicine
- Center of Regenerative Medicine
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Molecular Cell Biology
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- DBBS - Immunology
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations